Gosens and Sluimer in a prospective, randomized controlled trial of 100 patients with tennis elbow found PRP beat cortisone in terms of improvement in pain and function at 24 weeks. This excellent study (Level 1 evidence) for the first time confirms platelet rich plasma performs better than the "gold standard" of treatment for patients with tennis elbow that don't respond to simple treatments.
Gosen and his colleagues will be hosting a "Trends in Tendinopathy" course next week in Europe. AM will be presenting and in this space, I will report the details of that important conference.
Total Tendon
ApexPRP.com
